Jim Simons
AVXL icon

Jim Simons’s Anavex Life Sciences AVXL Stock Holding History

Jim Simons’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$850K Buy
276,800
+251,378
+989% +$1.09M ﹤0.01% 2349
2025
Q4 		$90.5K Buy
+25,422
New +$156K ﹤0.01% 3022
2025
Q2 		– Sell
-14,000
Closed -$120K – 3548
2025
Q1 		$120K Sell
14,000
-199,200
-93% -$1.88M ﹤0.01% 3164
2024
Q4 		$2.29M Sell
213,200
-30,600
-13% -$235K ﹤0.01% 1972
2024
Q3 		$1.38M Sell
243,800
-222,637
-48% -$1.28M ﹤0.01% 2249
2024
Q2 		$1.97M Buy
466,437
+386,537
+484% +$1.56M ﹤0.01% 1896
2024
Q1 		$407K Buy
+79,900
New +$450K ﹤0.01% 2954
2022
Q4 		– Sell
-367,100
Closed -$3.79M – 4109
2022
Q3 		$3.79M Buy
367,100
+9,300
+3% +$98.1K 0.01% 1609
2022
Q2 		$3.58M Buy
+357,800
New +$3.39M ﹤0.01% 1790
2021
Q1 		– Sell
-63,100
Closed -$341K – 3300
2020
Q4 		$341K Buy
+63,100
New +$333K ﹤0.01% 2988
2020
Q2 		– Sell
-407,400
Closed -$1.28M – 3426
2020
Q1 		$1.28M Buy
407,400
+325,859
+400% +$1.14M ﹤0.01% 2303
2019
Q4 		$211K Buy
+81,541
New +$214K ﹤0.01% 3184
2019
Q1 		– Sell
-18,109
Closed -$28K – 3437
2018
Q4 		$28K Buy
+18,109
New +$41.1K ﹤0.01% 3312

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jim Simons's AVXL Position: Q1 2026 in Review

Jim Simons increased its Anavex Life Sciences (AVXL) stake by 989% in Q1 2026, buying an estimated $1.09M and bringing the position to 276,800 shares worth $850K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

Jim Simons first reported a position in AVXL in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.79M in Q3 2022. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Jim Simons held 276,800 shares of Anavex Life Sciences worth $850K as of Q1 2026.
  • Jim Simons bought 251,378 Anavex Life Sciences shares in Q1 2026, an estimated $1.09M.
  • Anavex Life Sciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2349 holding.
  • Jim Simons first reported a position in Anavex Life Sciences in Q4 2018 and has held it in 13 quarters since.
  • Jim Simons's Anavex Life Sciences position peaked at $3.79M in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.